PSWE-08 - Pharmacy first

Ballroom West
Organised by The Technology Advisory Group in collaboration with the FIP Academic Pharmacy Section, the FIP Ethics Advisory Group,, the FIP Regulators Advisory Group and the FIP Early Career Pharmaceutical Group

Chair(s)

Dr Arijana Meštrović, ExCo Member FIP Academic Pharmacy Section, Croatia and Dr Sham Moodley, ExCo member of the FIP Community Pharmacy Section, South Africa

Introduction

Healthcare systems have undergone significant changes in the past few decades to meet the ever-increasing demands of delivering more complex care. Governments have issued a number of reports which call for healthcare delivery reform, highlighting the importance of ensuring the right healthcare professionals provide the right service at the right time. 

One international trend is the expanded scope of practice for pharmacists including primary healthcare reform, interprofessional collaboration, effective utilisation of health human resources and enhancing safety and outcomes of drug therapy. As medicine regimes become more specialised, the role of pharmacist independent prescribers (PIP) has become increasingly important in delivering high-quality clinical care. Greater use of PIPs within the multi-disciplinary team will expand patient access to care, improve capacity in the healthcare system and improve patient health outcomes. 

In many countries, pharmacists can initiate, continue or modify/adapt drug therapy, ranging from renewing a continued care prescription to independent prescriptive authority. Pharmacists are the most accessible healthcare professionals with the knowledge and skills to optimise drug therapy and improve health outcomes. Pharmacists, like all healthcare professionals, act in accordance with the codes of ethics and standards of practice of their profession. 

Developing and utilising clinical skills and capabilities of community pharmacists, supported by investment in training, is part of a wider shift across the health system to improve access to care in local communities and address health inequalities.

Programme

 

13:30 – 13:35

Introduction by the chair

13:35 – 14:05

Pharmacy first
Dr Adam Osprey, NHS Scotland, United Kingdom

14:05 – 14:35

The value of self-care for universal health coverage — The pharmacist’s role
Ms Nicola Brink, Self-Care Association of South Africa, South Africa

14:35 – 14:55 Panel discussion
14:55– 15:00 Closing

Learning objectives

  • To understand the new role of community pharmacy within Minor Ailment Schemes. 
  • To describe what is needed to become a prescribing pharmacist.
  • To outline key challenges for pharmacy becoming integrated into primary health care.
  • To describe the value of self-care for universal health coverage.

Summary

  • Understand the evolving role of the pharmacist as a prescriber in the new primary healthcare model.
  • Identify types of education needed.
  • Understand the “magic formula” for positioning pharmacy as the entry to primary health care with pharmacists as prescribers.
  • Understand the value of self-care for universal health coverage.